Polymorphisms at GLUT1 Gene Are Not Associated With the Development of TSP/HAM in Brazilian HTLV-1 Infected Individuals and the Discovery of a New Polymorphism at GLUT1 Gene


Autoria(s): COSTA, Giselle Calasans Souza; AZEVEDO, Rochele; GADELHA, Sandra Rocha; KASHIMA, Simone Haddad; MURICY, Gabriel; OLAVARRIA, Viviana Nila; COVAS, Dimas Tadeu; TAKAYANAGUI, Osvaldo Massaiti; GALVAO-CASTRO, Bernardo; ALCANTARA, Luiz Carlos Junior
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2009

Resumo

The development of HTLV-1 associated clinical manifestations, such as TSP/HAM and ATLL, occur in 2-4% of the infected population and it is still unclear why this infection remains asymptomatic in most infected carriers. Recently, it has been demonstrated that HTLV uses the Glucose transporter type 1 (GLUT1) to infect T-CD4(+) lymphocytes and that single nucleotide polymorphisms (SNP) in the GLUT1 gene are associated with diabetic nephropathy in patients with diabetes mellitus in different populations. These polymorphisms could contribute to a higher GLUT1 protein expression on cellular membrane, facilitating the entry of HTLV and its transmission cell by cell. This could result in a higher provirus load and consequently in the development of TSP/HAM. To evaluate the role of GLUT1 gene polymorphisms in the development of TSP/HAM in HTLV-1 infected individuals, the g.22999G > T, g.15339T > C and c.-2841A > T sites were analyzed by PCR/RFLP or sequencing in 244 infected individuals and 102 normal controls. The proviral load of the HTLV-1 infected patients was also analyzed using Real Time Quantitative PCR. Genotypic and allelic frequencies of the three sites did not differ significantly between controls and HTLV-1 infected individuals. There was no difference in genotypic and allelic distributions among patients as to the presence or absence of HTLV-1 associated clinic manifestations. As regards the quantification of the provirus load, we observed a significant reduction in the asymptomatic individuals compared with the oligosymptomatic and TSP/HAM individuals. These results suggest that g.22999G > T, g.15339T > C, and c.-2841A > T SNP do not contribute to HTLV-1 infection nor to the genetic susceptibility of TSP/HAM in Brazilian HTLV-1 infected individuals. J. Med. Virol. 81:552557, 2009. (C) 2009 Wiley-Liss, Inc.

Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)

Identificador

JOURNAL OF MEDICAL VIROLOGY, v.81, n.3, p.552-557, 2009

0146-6615

http://producao.usp.br/handle/BDPI/24659

10.1002/jmv.21421

http://dx.doi.org/10.1002/jmv.21421

Idioma(s)

eng

Publicador

WILEY-LISS

Relação

Journal of Medical Virology

Direitos

restrictedAccess

Copyright WILEY-LISS

Palavras-Chave #HTLV-1 #GLUT1 #polymorphisms #VIRUS TYPE-I #T-CELL LEUKEMIA #GLUCOSE-TRANSPORTER GLUT1 #TROPICAL SPASTIC PARAPARESIS #DEPENDENT DIABETES-MELLITUS #PROVIRAL LOAD #ETHNIC-DIFFERENCES #INTERLEUKIN-6 #NEPHROPATHY #SUSCEPTIBILITY #Virology
Tipo

article

original article

publishedVersion